Xcout Intel
Cellbox Labs
Cellbox Labs brings automation to organ-on-chip technology, simplifying adoption while reducing costs, saving time, and eliminating setup complexity. The company is also developing easy to use instruments to run experiments on the chips.
Subscribe to see Cellbox Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cellbox Labs at a glance
Cellbox Labs is a biotechnology company headquartered in Latvia. Its most recent funding round, Grant, raised $3.8M in August 2025. Xcout tracks 3 named people at Cellbox Labs, including Gatis Mozoļevskis (Co-founder and CEO).
Cellbox Labs leadership
- Gatis MozoļevskisCo-founder and CEO
- Roberts RimšaCo-founder and CTO
- Artūrs ĀbolsCo-founder and CSO
Cellbox Labs funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $3.8M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cellbox Labs competitors
A few of Cellbox Labs's closest competitors — see the full list of competitors and alternatives →
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Oroboros Instruments is a biotechnology company that develops high-resolution respirometry equipment and maintains the Bioblast knowledge base for mitochondrial research.
Cellbox Solutions develops warm-chain logistics technology and innovative products like portable incubators with active CO2 control to enable the global transport of living cells for the biomedical industry.
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting. This initiative is designed to provide clinicians with better data about how a
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Get Cellbox Labs's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cellbox Labs in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access